Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
Sponsor: Masonic Cancer Center, University of Minnesota
A PHASE2 clinical study on Childhood Germ Cell Tumor and Ovarian Cancer, this trial is completed. The trial is conducted by Masonic Cancer Center, University of Minnesota and has accumulated 15 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jun 2022 — Jul 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Dec 2021 — Jun 2022 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE2
▶ Show 10 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Sep 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Mar 2020 — Sep 2020 [monthly]
Recruiting PHASE2
-
Aug 2019 — Mar 2020 [monthly]
Recruiting PHASE2
-
Mar 2019 — Aug 2019 [monthly]
Recruiting PHASE2
-
Oct 2018 — Mar 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE2
-
May 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Dec 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Masonic Cancer Center, University of Minnesota
For direct contact, visit the study record on ClinicalTrials.gov .